Helicobacter pylori diagnostics market

Helicobacter Pylori Diagnostics Market, by Test Type (Invasive (Immunoassay, Rapid Urease Test and Histology) and Non-invasive (Stool Antigen Assay, Serology Tests and Urea Breath Test)), by End Users (Hospitals, Clinics, Diagnostic Laboratories and Others) and by Region - Global Forecast to 2026

Request Free Sample

Jun 2018
CMI1874
167 Pages
Excel & Pdf
Clinical Diagnostic

Summary

Helicobacter Pylori Diagnostics Market Insights – Quick Tests Allowing Efficient Diagnosis

Helicobacter is a spiral shaped gram-negative bacteria, causing chronic inflammation and infection in stomach and duodenum leading to ulceration. H. pylori is found in 50-80% of patients with gastric ulcers and in 90% of patients with duodenal ulcers. An estimated one in six individuals infected with H. pylori are expected to eventually develop peptic ulcer disease. Infected individuals experience long asymptomatic conditions with nearly 70% of individuals having minimal symptoms such as belching, bloating, nausea, vomiting, abdominal discomfort as occasional, whereas, major symptoms includes abdominal pain, peptic ulcer, bad breath etc. Helicobacter infection can be diagnosed by invasive that requires gastric mucosa samples, which are obtained through endoscopy and used for biopsy or non-invasive tests that requires blood or stool samples. Invasive tests include immunoassay, rapid urease test, and histology whereas non-invasive includes stool antigen assays serology tests and urea breath test.

The global Helicobacter pylori diagnostics market size was valued at US$ 437.3 million in 2017 and is expected to witness a CAGR of 7.1% over the forecast period (2018 – 2026).

Source: Coherent Market Insights (2018)

Increasing prevalence of helicobacter pylori in emerging economies is propelling the Helicobacter pylori diagnostics market growth

Prevalence of helicobacter pylori is declining in developed countries, whereas its prevalence in emerging economies is increasing. For instance, according to the Faculty of Medicine of The Chinese University of Hong Kong (CUHK), 2017, around 4.4 billion people worldwide are infected with Helicobacter pylori (H. pylori). Furthermore, same source suggested that prevalence in Africa is up to 80%, which is the highest globally, while in Asia, over 50% of the population was infected with H. pylori. Moreover, according to the International Agency for Research on Cancer report 2014, in 2012, around 952,000 new gastric cancer cases occurred globally and around 734,000 gastric cancers were estimated to occur due to H. pylori infection. Such high prevalence of Helicobacter pylori in Africa and Asia is expected to fuel the regional helicobacter market growth.

The limitations associated with diagnostic tests are expected to be a major factor restraining growth of the Helicobacter pylori diagnostics market. For instance, serology-based assays have low sensitivity and specificity, as they are unable to differentiate between active infection and IgG antibodies present in case of post treatment.

Africa market to exhibit fastest growth over the forecast period

Regionally, Helicobacter pylori diagnostics market is segmented into - North America, Latin America, Europe, Asia Pacific, Middle East, and Africa by Coherent Market Insights. North America Helicobacter pylori diagnostic market holds dominant position in the global market and this is attributed to initiatives to provide test kits at low costs to eradicate H. pylori infection. For instance, antibody-based detection tests are available at lower cost for enhancing the eradication of helicobacter pylori infection in Quebec. Moreover, Agence d’évaluation des technologies et des modes d’intervention en santé (AETMIS), an independent body reporting to the Quebec Minister of Health and Social Services, recommends the 13C-urea breath test to be made available in all areas of Québec. However, Africa Helicobacter pylori diagnostic market is expected to exhibit high CAGR, owing to high prevalence of Helicobacter pylori. According to studies published in Gastroenterology Journal, 2017, the data suggested that Africa has highest prevalence of H. pylori infection, which is around 79%.

Inorganic strategies by key players is fuelling growth of the Helicobacter pylori diagnostics market

Key players involved in the global Helicobacter pylori diagnostics market include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.), Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc., and Halyard Health, Inc.

Manufacturers are focusing on inorganic strategies, in order to enhance their product offerings. For instance, Diasorin S.P.A., in September 2017, acquired ELISA technology business from Siemens, with an aim of shifting the current client base that uses ELISA tests towards CLIA technology solutions. As a part of agreement, Siemens will continue to manufacture and supply ELISA immunodiagnostic kits exclusively for DiaSorin for the next three years.

Table of Content

Table of Contents

Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

*Browse 27 market data tables and 30 figures on “Helicobacter Pylori Diagnostics Market - Global forecast to 2026”.

N/A

- Frequently Asked Questions -

What are the growth estimates for Helicobacter pylori diagnostics market till 2026?

The global Helicobacter pylori diagnostics market is estimated to surpass US$ 807.4 Million by 2026.

Which are the prominent Helicobacter pylori diagnostics market players across the globe?

Major players operating in the global Helicobacter pylori diagnostics market include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.), Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc., and Halyard Health, Inc.

Which segment based on test type, accounted for the highest demand in the Helicobacter pylori diagnostics market?

Among test type, invasive segment is expected to hold dominant position, owing to introduction of better diagnostic assay with high sensitivity and specificity.

What are the key factors driving growth of the Helicobacter pylori diagnostics market?

Increasing prevalence of helicobacter pylori in emerging economies is one of the major factors that is expected to propel growth of the market over the forecast period.

What is the Compound Annual Growth Rate (CAGR) of the Helicobacter pylori diagnostics market for next 8 years?

The global Helicobacter pylori diagnostics market is estimated to exhibit a CAGR of 7.1% over the forecast period.

Which region is dominating the Helicobacter pylori diagnostics market growth?

Among regions, North America is expected to hold dominant position in the market over the forecast period.